Cancer, once a formidable foe with limited treatment options, is facing a revolution. The oncology drugs market, fueled by scientific advancements and a rising global cancer burden, presents a compelling landscape for investors seeking to make a difference. This market, projected for significant growth, offers diverse opportunities alongside crucial considerations for those looking to navigate...